Intratympanic Treatment of Intractable Unilateral Ménière Disease
- 18 November 2011
- journal article
- research article
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 146 (3) , 430-437
Abstract
Objective. To determine the efficacy and safety of low-dose intratympanic gentamicin (ITG) compared with intratympanic dexamethasone (ITD) in patients with intractable unilateral Ménière disease (MD).Keywords
This publication has 38 references indexed in Scilit:
- Evidence-Based Modification of Intratympanic Gentamicin Injections in Patients With Intractable VertigoOtology & Neurotology, 2010
- Intratympanic Steroids for Inner Ear Disorders: A ReviewAudiology and Neurotology, 2009
- Cochlear blood flow during occlusion and reperfusion of the anterior inferior cerebellar artery – effect of topical application of dexamethasone to the round windowActa Oto-Laryngologica, 2009
- Medical Management Of Ménière's DiseaseThe Laryngoscope, 2008
- Longitudinal Results With Intratympanic Dexamethasone in the Treatment of Ménière's DiseaseOtology & Neurotology, 2008
- Demonstration of a Longitudinal Concentration Gradient Along Scala Tympani by Sequential Sampling of Perilymph from the Cochlear ApexJournal of the Association for Research in Otolaryngology, 2006
- Glucocorticoid regulation of genes in the amiloride-sensitive sodium transport pathway by semicircular canal duct epithelium of neonatal ratPhysiological Genomics, 2006
- Changes in aquaporin expression in the inner ear of the rat after i.p. injection of steroidsActa Oto-Laryngologica, 2004
- Intratympanic Steroid Injections for Intractable Ménière's DiseaseThe Laryngoscope, 2001
- Intratympanic and Systemic Dexamethasone for Ménière’s DiseaseORL, 2000